FMS: Rega marang dodolan Fresenius Medical Care Corp

Tandha merek Fresenius Medical Care Corp (FMS)

The normalized P/S of Fresenius Medical Care (FMS) illustrates the valuation dynamics of a company striving for global leadership in dialysis through mergers and AI technologies. The current value of 0.50 shows the real-time magnitude of the multiple. The business generates revenue from equipment sales and clinics for kidney patients, while stable demand for hemodialysis ensures a steady cash flow and operational resilience.

FMS (Fresenius Medical Care AG & Co. KGaA) riwayat Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Fresenius Medical Care Corp (FMS)

Ringkesan analitik perusahaan:freseniusmedicalcare.com, FMS
Produk mawa merek Fresenius Medical Care

Fresenius Medical Care maintains a stable revenue stream driven by its status as a global leader in dialysis and patient trust, which serves as the foundation for calculating the P/S ratio. This metric compares market capitalization to annual revenue, allowing this price-to-sales chart to identify unjustified growth in asset valuation amid stagnating sales, signaling a risk of a deep correction.

Pesaing Fresenius Medical Care

Koefisien rega marang pendapatan hcahealthcare.com|Multiplikator P/S THC (Tenet Healthcare Corporation)|Solventum Corp (SOLV) - Rega marang dodolan|EHC - Rasio rega marang pendapatan|UHS (Universal Health Services) - Rasio kapitalisasi marang pendapatan|DVA: Multiplikator P/S|RDNT - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan OPCH|Multiplikator P/S Surgery Partners Inc|Rasio rega marang pendapatan Premier Corp (PINC)|Koefisien rega marang pendapatan America's Best Contacts & Eyeglasses|Progyny, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ARDT|SEM - Rasio rega marang pendapatan|Astrana Health Inc (ASTH) - Kapitalisasi marang pendapatan|MD: Multiplikator P/S|Rega marang dodolan U.S. Physical Therapy, Inc. (USPH)|PNTG (The Pennant Group, Inc.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ORGO (organogenesis.com)|Multiplikator P/S NUTX|Koefisien rega marang pendapatan Auna S.A.|Multiplikator P/S SBC (SBC Medical Group Holdings Inc.)|EOLS - Kapitalisasi marang pendapatan|Community Health Systems - Multiplikator P/S|SKIN - Multiplikator P/S|mediwound.com (MDWD) - Rasio rega marang pendapatan|BTMD (Biote) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan JYNT|DCGO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PIII|Kapitalisasi marang pendapatan gaintherapeutics.com GANX|Multiplikator P/S EUDA (EUDA Health Holdings Limited)|Multiplikator P/S Basel Medical BMGL|CLGN - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CUPR (Cuprina Holdings Limited)|CCM: Multiplikator P/S|Rega marang dodolan ashs.com (AMS)|MRM (MEDIROM Healthcare Group) - Multiplikator P/S|Avalon GloboCare Corporation - Rasio rega marang dodolan|Rasio rega marang pendapatan DIH Holding US Inc. (DHAI)|Kapitalisasi marang pendapatan Carmell Corp XAGE|Rasio rega marang pendapatan NewGenIvf Group Limited NIVF|Koefisien rega marang pendapatan ATI Physical Therapy Inc. (ATIP)|CMAX: Kapitalisasi marang pendapatan|Kindly MD Inc - Kapitalisasi marang volume dodolan|LogistiCare (MODV) - Rasio rega marang pendapatan|Novo Integrated Sciences Corp - Rasio kapitalisasi pasar marang pendapatan|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|Rega marang dodolan imacholdings.comm BACK